Catestatin decreases macrophage function in two mouse models of experimental colitis

Biochemical Pharmacology

Volumn 89, Issue 3, 2014, Pages 386-398

  Rabbi, Mohammad F ^a   Labis, Benoit ^a   Metz Boutigue, Marie Hélène ^b   Bernstein, Charles N ^a   Ghia, Jean Eric ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Catestatin; Chromogranin A; Experimental colitis; Macrophages; STAT3

Indexed keywords

CATESTATIN; CYTOKINE; DEXTRAN SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; CYTOKINE RELEASE; EXPERIMENTAL COLITIS; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MACROPHAGE FUNCTION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

CATESTATIN; CHROMOGRANIN A; EXPERIMENTAL COLITIS; MACROPHAGES; STAT3;

ANIMALS; BENZENESULFONATES; CHROMOGRANIN A; COLITIS; DEXTRAN SULFATE; HUMANS; INFLAMMATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; SERUM; STAT3 TRANSCRIPTION FACTOR;

EID: 84899929120     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2014.03.003     Document Type: Article

References (69)

1. N.A. Molodecky, I.S. Soon, D.M. Rabi, W.A. Ghali, M. Ferris, and G. Chernoff et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review Gastroenterology 142 2012 46 54 e42; quiz e30
2. X. Han, N. Benight, B. Osuntokun, K. Loesch, S.J. Frank, and L.A. Denson Tumour necrosis factor alpha blockade induces an anti-inflammatory growth hormone signalling pathway in experimental colitis Gut 56 2007 73 81
3. A.N. Ananthakrishnan, M. Issa, A. Barboi, S. Jaradeh, Y. Zadvornova, and S. Skaros et al. Impact of autonomic dysfunction on inflammatory bowel disease J Clin Gastroenterol 44 2010 272 279
4. E. Domenech Inflammatory bowel disease: current therapeutic options Digestion 73 Suppl 1 2006 67 76
5. S. Vermeire, G. van Assche, and P. Rutgeerts Review article: altering the natural history of Crohn's disease - evidence for and against current therapies Aliment Pharmacol Ther 25 2007 3 12
6. K.A. Papadakis, and S.R. Targan Role of cytokines in the pathogenesis of inflammatory bowel disease Annu Rev Med 51 2000 289 298
7. D.K. Podolsky Inflammatory bowel disease (1) N Engl J Med 325 1991 928 937
8. M. El-Salhy, A. Danielsson, R. Stenling, and L. Grimelius Colonic endocrine cells in inflammatory bowel disease J Intern Med 242 1997 413 419
9. H.L. Waldum, U. Syversen, and A. Chromogranin (CGA) and the enterochromaffin-like (ECL) cell Adv Exp Med Biol 482 2000 361 367
10. J.E. Ghia, F. Crenner, M.H. Metz-Boutigue, D. Aunis, and F. Angel The effect of a chromogranin A-derived peptide (CgA4-16) in the writhing nociceptive response induced by acetic acid in rats Life Sci 75 2004 1787 1799
11. J.E. Ghia, F. Crenner, S. Rohr, C. Meyer, M.H. Metz-Boutigue, and D. Aunis et al. A role for chromogranin A (4-16), a vasostatin-derived peptide, on human colonic motility. An in vitro study Regul Pept 121 2004 31 39
12. W.J. Curry, C.F. Johnston, J.C. Hutton, S.D. Arden, N.G. Rutherford, and C. Shaw et al. The tissue distribution of rat chromogranin A-derived peptides: evidence for differential tissue processing from sequence specific antisera Histochemistry 96 1991 531 538
13. N.G. Seidah, and M. Chretien Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides Brain Res 848 1999 45 62
14. L.E. Eiden Is chromogranin a prohormone? Nature 325 1987 301
15. Y.P. Loh, Y. Cheng, S.K. Mahata, A. Corti, and B. Tota Chromogranin A and derived peptides in health and disease J Mol Neurosci 48 2012 347 356
16. N.R. Mahapatra, D.T. O'Connor, S.M. Vaingankar, A.P. Hikim, M. Mahata, and S. Ray et al. Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog J Clin Invest 115 2005 1942 1952
17. S.K. Mahata, M. Mahata, M.M. Fung, and D.T. O'Connor Catestatin: a multifunctional peptide from chromogranin A Regul Pept 162 2010 33 43
18. S.K. Mahata, D.T. O'Connor, M. Mahata, S.H. Yoo, L. Taupenot, and H. Wu et al. Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist J Clin Invest 100 1997 1623 1633
19. D. Zhang, P. Shooshtarizadeh, B.J. Laventie, D.A. Colin, J.F. Chich, and J. Vidic et al. Two chromogranin a-derived peptides induce calcium entry in human neutrophils by calmodulin-regulated calcium independent phospholipase A2 PLoS One 4 2009 e4501
20. X. Guo, C. Zhou, and N. Sun The neuropeptide catestatin promotes vascular smooth muscle cell proliferation through the Ca2+-calcineurin-NFAT signaling pathway Biochem Biophys Res Commun 407 2011 807 812
21. M. Hironaka, T. Ansai, I. Soh, A. Ishisaka, S. Awano, and A. Yoshida et al. Association between salivary levels of chromogranin A and periodontitis in older Japanese Biomed Res 29 2008 125 130
22. G. di Comite, A. Marinosci, P. Di Matteo, A. Manfredi, P. Rovere-Querini, and E. Baldissera et al. Neuroendocrine modulation induced by selective blockade of TNF-alpha in rheumatoid arthritis Ann NY Acad Sci 1069 2006 428 437
23. V. Sciola, S. Massironi, D. Conte, F. Caprioli, S. Ferrero, and C. Ciafardini et al. Plasma chromogranin a in patients with inflammatory bowel disease Inflamm Bowel Dis 15 2009 867 871
24. M. El-Salhy, B. Lomholt-Beck, and T.D. Gundersen High chromogranin A cell density in the colon of patients with lymphocytic colitis Mol Med Rep 4 2011 603 605
25. M. Wagner, M. Stridsberg, C.G. Peterson, P. Sangfelt, M. Lampinen, and M. Carlson Increased fecal levels of chromogranin A, chromogranin B, and secretoneurin in collagenous colitis Inflammation 36 4 2013 855 861 10.1007/s10753-013-9612-4
26. U. Nieminen, A. Jussila, S. Nordling, H. Mustonen, and M.A. Farkkila Inflammation and disease duration have a cumulative effect on the risk of dysplasia and carcinoma in IBD: A case-control observational study based on registry data Int J Cancer 134 1 2014 189 196 10.1002/ijc.28346
27. S. Sebastian, V. Hernandez, P. Myrelid, R. Kariv, E. Tsianos, and M. Toruner et al. Colorectal cancer in inflammatory bowel disease: Results of the 3rd ECCO pathogenesis scientific workshop (I) J Crohns Colitis 8 1 2014 5 18 10.1016/j.crohns.2013.04.008
28. M. Mason, and C.A. Siegel Do inflammatory bowel disease therapies cause cancer Inflamm Bowel Dis 19 2013 1306 1321
29. C. Rumio, G.F. Dusio, B. Colombo, A. Gasparri, D. Cardani, and F. Marcucci et al. The N-terminal fragment of chromogranin A, vasostatin-1 protects mice from acute or chronic colitis upon oral administration Dig Dis Sci 57 2012 1227 1237
30. N. Watanabe, K. Ikuta, K. Okazaki, H. Nakase, Y. Tabata, and M. Matsuura et al. Elimination of local macrophages in intestine prevents chronic colitis in interleukin-10-deficient mice Dig Dis Sci 48 2003 408 414
31. A.A. te Velde, Y. van Kooyk, H. Braat, D.W. Hommes, T.A. Dellemijn, and J.F. Slors et al. Increased expression of DC-SIGN + IL-12 + IL-18+ and CD83 + IL-12-IL-18- dendritic cell populations in the colonic mucosa of patients with Crohn's disease Eur J Immunol 33 2003 143 151
32. S. Vuckovic, T.H. Florin, D. Khalil, M.F. Zhang, K. Patel, and I. Hamilton et al. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases Am J Gastroenterol 96 2001 2946 2956
33. J.E. Ghia, F. Galeazzi, D.C. Ford, C.M. Hogaboam, B.A. Vallance, and S.M. Collins Role of M-CSF dependent macrophages in colitis is driven by the nature of the inflammatory stimulus Am J Physiol Gastrointest Liver Physiol 294 2008 770 777
34. S.H. Dave, J.S. Tilstra, K. Matsuoka, F. Li, T. Karrasch, and J.K. Uno et al. Amelioration of chronic murine colitis by peptide-mediated transduction of the IkappaB kinase inhibitor NEMO binding domain peptide J Immunol 179 2007 7852 7859
35. I. Okayasu, S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice Gastroenterology 98 1990 694 702
36. J.E. Ghia, P. Blennerhassett, and S.M. Collins Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression J Clin Invest 118 2008 2209 2218
37. H.S. Cooper, S.N. Murthy, R.S. Shah, and D.J. Sedergran Clinicopathologic study of dextran sulfate sodium experimental murine colitis Lab Invest 69 1993 238 249
38. M. Kruisbeek, and S. Vogel Innate immunity: isolation of murine macrophage Curr Protoc Immunol 2002 14.1.1-2.8
39. A.H. Fortier, and L.A. Falk Isolation of murine macrophages Curr Protoc Immunol 2001 10.1002/0471142735.im1401s11 Chapter 14: Unit 14.1
40. C.B. Appleyard, and J.L. Wallace Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs Am J Physiol 269 1995 G119 G125
41. N.K. Boughton-Smith, J.L. Wallace, and B.J. Whittle Relationship between arachidonic acid metabolism, myeloperoxidase activity and leukocyte infiltration in a rat model of inflammatory bowel disease Agents Actions 25 1988 115 123
42. P.P. Bradley, D.A. Priebat, R.D. Christensen, and G. Rothstein Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker J Invest Dermatol 78 1982 206 209
43. G.K. Bandyopadhyay, C.U. Vu, S. Gentile, H. Lee, N. Biswas, and N.W. Chi et al. Catestatin (chromogranin A(352-372)) and novel effects on mobilization of fat from adipose tissue through regulation of adrenergic and leptin signaling J Biol Chem 287 2012 23141 23151
44. R. Sidhu, K. Drew, M.E. McAlindon, A.J. Lobo, and D.S. Sanders Elevated serum chromogranin A in irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD): a shared model for pathogenesis? Inflamm Bowel Dis 16 2010 361
45. M.F. Neurath, I. Fuss, B.L. Kelsall, E. Stuber, and W. Strober Antibodies to interleukin 12 abrogate established experimental colitis in mice J Exp Med 182 1995 1281 1290
46. D.R. Linden, J.X. Chen, M.D. Gershon, K.A. Sharkey, and G.M. Mawe Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis Am J Physiol Gastrointest Liver Physiol 285 2003 G207 G216
47. S. Oshima, M. Fujimura, and M. Fukimiya Changes in number of serotonin-containing cells and serotonin levels in the intestinal mucosa of rats with colitis induced by dextran sodium sulfate Histochem Cell Biol 112 1999 257 263
48. J.M. Conlon Granin-derived peptides as diagnostic and prognostic markers for endocrine tumors Regul Pept 165 2010 5 11
49. M. El-Salhy Colonic endocrine cells in inflammatory bowel disease J Inter Med 242 1997 413 419
50. R. Sidhu, M.E. McAlindon, J.S. Leeds, J. Skilling, and D.S. Sanders The role of serum chromogranin A in diarrhoea predominant irritable bowel syndrome J Gastrointestin Liver Dis 18 2009 23 26
51. S.P. Dunlop, D. Jenkins, K.R. Neal, and R.C. Spiller Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS Gastroenterology 125 2003 1651 1659
52. J.W. Smith, and G.A. Castro Relation of peroxidase activity in gut mucosa to inflammation Am J Physiol 234 1978 R72 R79
53. D. Zhang, T. Lavaux, R. Sapin, T. Lavigne, V. Castelain, and D. Aunis et al. Serum concentration of chromogranin A at admission: an early biomarker of severity in critically ill patients Ann Med 41 2009 38 44
54. D. Zhang, T. Lavaux, A.C. Voegeli, T. Lavigne, V. Castelain, and N. Meyer et al. Prognostic value of chromogranin A at admission in critically ill patients: a cohort study in a medical intensive care unit Clin Chem 54 2008 1497 1503
55. R.B. Sartor Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases Am J Gastroenterol 92 1997 5S 11S
56. M. Schenk, and C. Mueller Adaptations of intestinal macrophages to an antigen-rich environment Semin Immunol 19 2007 84 93
57. S.T. Henriques, M.N. Melo, and M.A. Castanho Cell-penetrating peptides and antimicrobial peptides: how different are they Biochem J 399 2006 1 7
58. T. Alonzi, I.P. Newton, P.J. Bryce, E. Di Carlo, G. Lattanzio, and M. Tripodi et al. Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitis Cytokine 26 2004 45 56
59. K. Takeda, B.E. Clausen, T. Kaisho, T. Tsujimura, N. Terada, and I. Forster et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils Immunity 10 1999 39 49
60. H. Yasukawa, M. Ohishi, H. Mori, M. Murakami, T. Chinen, and D. Aki et al. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages Nat Immunol 4 2003 551 556
61. A. Suzuki, T. Hanada, K. Mitsuyama, T. Yoshida, S. Kamizono, and T. Hoshino et al. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation J Exp Med 193 2001 471 481
62. P. Lovato, C. Brender, J. Agnholt, J. Kelsen, K. Kaltoft, and A. Svejgaard et al. Constitutive STAT3 activation in intestinal T cells from patients with Crohn's disease J Biol Chem 278 2003 16777 16781
63. W.I. Khan, P.A. Blennerhasset, A.K. Varghese, S.K. Chowdhury, P. Omsted, and Y. Deng et al. Intestinal nematode infection ameliorates experimental colitis in mice Infect Immun 70 2002 5931 5937
64. B.S. Qiu, B.A. Vallance, P.A. Blennerhassett, and S.M. Collins The role of CD4+ lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis Nat Med 5 1999 1178 1182
65. P.G. Kruger, S.K. Mahata, and K.B. Helle Catestatin (chromogranin A344-358) stimulates release of histamine from rat pleural and peritoneal mast cells Ann NY Acad Sci 971 2002 349 351
66. R. Aslam, M. Atindehou, T. Lavaux, Y. Haikel, F. Schneider, and M.H. Metz-Boutigue Chromogranin A-derived peptides are involved in innate immunity Curr Med Chem 19 2012 4115 4123
67. K. Klimesova, M. Kverka, Z. Zakostelska, T. Hudcovic, T. Hrncir, and R. Stepankova et al. Altered gut microbiota promotes colitis-associated cancer in IL-1 receptor-associated kinase M-deficient mice Inflamm Bowel Dis 19 2013 1266 1277
68. M. Mori, K. Mimori, T. Kamakura, Y. Adachi, Y. Ikeda, and K. Sugimachi Chromogranin positive cells in colorectal carcinoma and transitional mucosa J Clin Pathol 48 1995 754 758
69. J. Liang, M. Nagahashi, E.Y. Kim, K.B. Harikumar, A. Yamada, and W.C. Huang et al. Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer Cancer Cell 23 2013 107 120